New eye dye could make retinal scans safer and sharper

NCT ID NCT04008121

Recruiting now Diagnosis Sponsor: MediBeacon Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new dye called MB-102 for taking pictures of the back of the eye (retina) to diagnose conditions like diabetic retinopathy and macular degeneration. About 10 adults with healthy or diseased eyes will receive both the new dye and a standard dye to compare safety and image quality. The goal is to see if MB-102 works as well as or better than the current dye.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic retinopathy macular degeneration retinal disorder retinal vascular disorder retinal vein occlusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC RETINOPATHY MACULAR DEGENERATION RETINAL VEIN OCCLUSION RETINOPATHY

Contacts and locations

Locations

University of Michigan Kellogg Eye Center
RECRUITING

Ann Arbor, Michigan, 48105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.